Markets:

Overview

News

Currencies

International

Treasuries

HEALTHCARE (NY:XLV)

148.36 -0.47 (-0.32%)

Streaming Delayed Price Updated: 10:25 AM EDT, Apr 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about HEALTHCARE

< Previous 1 2 Next >

Defensive Sectors: Shielding Your Portfolio in Volatile Times

September 07, 2024

Defensive sectors like consumer staples, healthcare, real estate, and utilities tend to perform well during market downturns and heightened volatility.

Via MarketBeat

Topics Economy Stocks

Amgen's MariTide Weight Loss Potential: Stock Outlook

August 07, 2024

Amgen's shares fell 2.4% after-hours trading due to a mixed earnings release. MariTide, the company's weight loss drug, is in Phase II FDA trials.

Via MarketBeat

Topics Intellectual Property

MarketBeat Week in Review – 7/29 - 8/2

August 03, 2024

The tech-led sell-off expanded and accelerated to close the week; more volatility may be the norm for the rest of the summer, which may force the Fed to move

Via MarketBeat

Topics Economy Stocks

Top 2 Cheap Healthcare Stocks to Buy as Sector Outperforms

July 30, 2024

The healthcare sector, represented by the XLV ETF, has seen a resurgence, breaking out of a multi-year consolidation phase and surging almost 3% in July.

Via MarketBeat

Topics ETFs

Pharma Leader Beats on Earnings, But Shares Fall

July 19, 2024

Novartis released its Q2 financial results. It beat expectations on EPS and revenue. However, shares fell, possibly due to bad news on one upcoming drug.

Via MarketBeat

Topics Intellectual Property

The Top 3 Sectors Poised For Growth This Summer

June 24, 2024

Communications, technology, and healthcare are the three hottest sectors for growth, but not all stocks will rise with the tides.

Via MarketBeat

Topics ETFs

Hims & Hers Health Stock Could Become a Wealth Compounder

May 07, 2024

Hims & Hers stock could give investors the best of both stability and double-digit upside through EPS projections and price targets, especially after 1Q24

Via MarketBeat

Topics Economy

CVS Stock is Nearing a 52-Week Low, Better Buy Than Walgreens?

April 30, 2024

CVS stock is making its way above Walgreens as a potential watchlist addition. Fundamentals and price targets see the stock making a comeback this year.

Via MarketBeat

Citi’s Results Say This About The Stock Market

April 15, 2024

Investors now have an inside look at what one of Wall Street's biggest names is doing with its money. Corporations and clients all see new highs in stocks

Via MarketBeat

Topics Economy

3 High Dividend Socks to Replace Lower Savings Yields Ahead

April 09, 2024

Three stocks stand out as the most attractive dividend propositions, particularly now that savings yields may drop as a result of the Fed's rate cuts

Via MarketBeat

Topics Economy

Nvidia's AI Tech Part of Novo Nordisk's New Supercomputer

March 24, 2024

Novo Nordisk and Nvidia have teamed up to develop supercomputers, aiming to accelerate drug discovery development using advanced AI technologies.

Via MarketBeat

Topics Artificial Intelligence

bluebird bio Stock Signals Potential to be a Multi-bagger

February 29, 2024

Driving a bargain of a short squeeze play, Bluebird Bio stock could soon announce what every investor is hoping to hear, here's what management could do

Via MarketBeat

Topics Economy

bluebird bio stock is ripe for a 400% institutional short squeeze

February 27, 2024

Bluebird Bio stock could be on the verge of a 400% pop on earnings, management has set the writing on the wall for institutional buying to trickle in

Via MarketBeat

Topics Economy

S&P 500 rockets to new highs as earnings beat estimates

February 09, 2024

The S&P 500 hits new highs as 10 of the 11 S&P sectors report positive Q4 earnings surprises. The tech and energy sectors are among the earnings leaders.

Via MarketBeat

Topics ETFs Earnings Stocks

Can financial, healthcare, energy stocks rise as rates stay high?

February 08, 2024

Sectors including financials, healthcare, utilities and energy outperform as interest rates remain high, but some of those industries face challenges in 2024.

Via MarketBeat

Markets suddenly price Eli Lilly stock for a breakout on earnings

February 05, 2024

The healthcare sector could see a sudden inflow of investment dollars, and Eli Lilly quickly becomes a favorite name in the space as markets and analysts bid up

Via MarketBeat

Topics Bonds Economy

Pfizer’s earnings growth trade at a deep discount, suddenly a buy

January 29, 2024

The healthcare sector is set to attract a new inflow of investment dollars, as seen in business activity and employment. Pfizer is the clear sector favorite

Via MarketBeat

Topics Economy

5 top healthcare stocks for earnings growth in 2024

January 25, 2024

2024 holds promise for healthcare stocks, with Humana, Elevance, and others expected to boost earnings, as analysts say many industry pressures have been removed.

Via MarketBeat

Are CVS store closures prescription for better financial health?

January 17, 2024

CVS plans to close dozens of Target pharmacies starting in February. Amid retail pharmacy challenges, CVS is shifting toward the managed-care industry.

Via MarketBeat

Topics Economy

UnitedHealth's rising premiums could cushion stubborn inflation

January 17, 2024

The healthcare sector is one of the prime suspects to attract safety-seeking investors in the coming market shift. Within it, THIS stock can prove a winner

Via MarketBeat

Topics Economy

AstraZeneca: Rebound in 2024 with double-digit earnings growth

January 11, 2024

AstraZeneca's stock rose 8.95% in the past month on a bullish outlook, driven by growing sales of cancer and diabetes drugs and a strategic acquisition

Via MarketBeat

HCA Healthcare Rallies: Weight-loss drugs really a big threat?

January 08, 2024

HCA Healthcare rebounds amid concerns about weight-loss drugs' impact. The healthcare giant's revenue growth hints at resilience despite sector challenges.

Via MarketBeat

Topics ETFs

Are defensive sectors ready to outshine growth in 2024?

January 06, 2024

Is 2024 the year defensive stocks rotate into leadership? As the year gets underway, defensives such as healthcare, energy, utilities and consumer staples lead.

Via MarketBeat

Align Technology: Protected by more factors than any other stock

December 26, 2023

Jobs are flowing to the healthcare space, and investment dollars are finding a home in stocks like Align Technology, even the CEO thought it to be the best

Via MarketBeat

Pfizer's chaotic year wraps up with plunging stock, grim guidance

December 21, 2023

Pfizer's tumultuous 2023 included a 41.84% stock plunge as revenue from Covid drugs fell. Disappointing 2024 guidance resulted in analysts slashing targets.

Via MarketBeat

Mega merger in the works? Humana, Cigna explore big deal

December 02, 2023

Humana and Cigna are exploring a merger, aiming to conclude the deal before year-end, creating a healthcare giant with a potential market value of $137 billion.

Via MarketBeat

These are the top sectors for blue chip growth in 2024

November 29, 2023

The sector results will be mixed in 2024 but the Health Care, Communications and Technology sectors (and some of their stocks) will post robust gains.

Via MarketBeat

Topics Economy Intellectual Property

J&J, Gilead, BMS: A look at undervalued dividend payers

November 29, 2023

J&J, Gilead and Bristol Myers are among healthcare stocks with defensive qualities amid market volatility and a potential economic slowdown

Via MarketBeat

Investor patience tested as pharmaceutical stocks take a tumble

November 01, 2023

The healthcare sector faces a selloff as pharmaceutical giants report lackluster earnings; even Amgen's strong results failed to prevent selling in the sector

Via MarketBeat

J&J stock down as business unit mulls talc-related bankruptcy

October 31, 2023

Johnson & Johnson stock fell in the past week as talc-related lawsuits weigh on a subsidiary, which is mulling bankruptcy to mitigate payouts and settlements.

Via MarketBeat

Topics Bankruptcy Lawsuit

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.